Question 1

What's the Alivus Life Sciences Ltd share price today?

Accepted Answer

Alivus Life Sciences Ltd share price was Rs 1,066.05 at 04:01 PM IST on 4th May 2026. Alivus Life Sciences Ltd share price was up by 2.75% over the previous closing price of Rs 1,037.50. Alivus Life Sciences Ltd share price trend:

Last 1 Month: Alivus Life Sciences Ltd share price moved up by 8.28% on BSE
Last 3 Months: Alivus Life Sciences Ltd share price moved up by 13.86% on BSE
Last 12 Months: Alivus Life Sciences Ltd share price moved down by 1.80% on BSE
Last 3 Years: Alivus Life Sciences Ltd price moved up by 112.06% on BSE

Question 2

How can I quickly analyse the performance of the Alivus Life Sciences Ltd stock?

Accepted Answer

The performance of the Alivus Life Sciences Ltd stock can be quickly analysed on the following metrics:

The stock's PE is 37.27
Price to book value ratio is 7.23
Dividend yield of 4.82
The EPS (trailing 12 months) of the Alivus Life Sciences Ltd stock is Rs 28.69

Question 3

What is the market cap of Alivus Life Sciences Ltd?

Accepted Answer

Alivus Life Sciences Ltd has a market capitalisation of Rs 13,086 crore.

Question 4

What is Alivus Life Sciences Ltd's 52-week high/low share price?

Accepted Answer

The Alivus Life Sciences Ltd’s 52-week high share price is Rs - and 52-week low share price is Rs -.

Question 5

Is the Alivus Life Sciences Ltd profitable?

Accepted Answer

On a consolidated basis, Alivus Life Sciences Ltd reported a loss of Rs undefined crore on a total income of Rs  crore for the quarter ended . For the year ended Dec 2025, Alivus Life Sciences Ltd had posted a profit of Rs 150.26 crore on a total income of Rs 686.82 crore.

Question 6

Which are Alivus Life Sciences Ltd’s peers in the Health care sector?

Accepted Answer

Alivus Life Sciences Ltd’s top 5 peers in the Health care sector are  Alembic Pharma, Jubilant Pharmo, Caplin Point Lab, Alivus Life, Concord Biotech, Sanofi Consumer, Corona Remedies.

Question 7

Who owns how much in Alivus Life Sciences Ltd?

Accepted Answer

Key changes to the Alivus Life Sciences Ltd shareholding are as follows:

Promoter holding in Alivus Life Sciences Ltd has gone down to 74.87 per cent as of Mar 2026 from 74.94 per cent as of Jun 2025.
Indian Public holding in Alivus Life Sciences Ltd has gone down to 9.87 per cent as of Mar 2026 from 10.33 per cent as of Jun 2025.
Mutual Funds Uti holding in Alivus Life Sciences Ltd has gone up to 5.63 per cent as of Mar 2026 from 4.06 per cent as of Jun 2025.
Foreign Institutional Investors holding in Alivus Life Sciences Ltd has gone down to 5.29 per cent as of Mar 2026 from 6.42 per cent as of Jun 2025.
Non Institutional Investors holding in Alivus Life Sciences Ltd has gone down to 2.69 per cent as of Mar 2026 from 2.70 per cent as of Jun 2025.
Other Institutional Investors holding in Alivus Life Sciences Ltd has gone up to 1.38 per cent as of Mar 2026 from 1.37 per cent as of Jun 2025.
Insurance Companies holding in Alivus Life Sciences Ltd has gone up to 0.27 per cent as of Mar 2026 from 0.18 per cent as of Jun 2025.
Financial Institutions holding in Alivus Life Sciences Ltd has gone up to 0.00 per cent as of Mar 2026 from 0.00 per cent as of Jun 2025.
Custodians holding in Alivus Life Sciences Ltd has gone up to 0.00 per cent as of Mar 2026 from 0.00 per cent as of Jun 2025.

Market Cap (₹ Cr)	13,086
Traded Value (₹ Cr)	0.59
Volume (Shares)	5,516
Face Value (₹)	2

52-Week High (₹)	-
52-Week High Date	-
52-Week Low (₹)	-
52-Week Low Date	-

All Time High (₹)	-
All Time High Date	-
All Time Low (₹)	-
All Time Low Date	-

Alivus Life Sciences Share Price

Alivus Life Sciences Ltd